Fertility projections used in analysis.

<p>This figure depicts the three different fertility scenarios used in analysis, from 2007 onwards. TFRc-: Total fertility rate in the absence of contraceptive use; TFR (baseline): Current and projected TFR; wTFR: TFR if only wanted births are considered.</p

Estimated effects of a 80% ARV-PMTCT uptake or 50% FP use among HIV-infected women, 2008–2012.

<p>Note: *The column “Total” estimates the number of events or person years as given by the baseline projection, in the presence of the actual estimated uptake of ARV-PMTCT and FP.</p>**<p>The columns “ARV-PMTCT” and “FP use” indicate the number of events (person characteristic) that would occur in addition in their respective absence. Negative values denote increases.</p><p>Percent estimates: the denominator is give by the number in the absence of the intervention; the numerator indicates the number of events averted. CTX: cotrimoxazole. PY: person-years. FP: Family planning. 80% ARV-PMTCT uptake and 50% FP use (among HIV+ women) are scaled up beginning 2009 and reach their goals by 2012.</p

Estimated effects of ARV-PMTCT, FP, and unwanted fertility on pediatric HIV, 2008–2012.

<p>Note: PY: person-years. CTX: cotrimoxazole.</p

Estimated effects of a 80% ARV-PMTCT uptake or 50% FP use among HIV-infected women, by 2012.

<p>Note: All values shown apply to the year 2012 only.</p

The projected 4 year costs once the transport network is established.

<p>The projected 4 year costs once the transport network is established.</p

Estimated costs different aspects of sample analysis.

<p>Estimated costs different aspects of sample analysis.</p

The recommended turnaround time measured as the time from collection of a sample to receipt of the results was about 28

<p>The recommended turnaround time measured as the time from collection of a sample to receipt of the results was about 28</p

How Turnaround Time reduced; sample and result transit time dropped from 49 days before lab consolidation to 26 day and from 26 to 14 days due to the NSRTN.

<p>How Turnaround Time reduced; sample and result transit time dropped from 49 days before lab consolidation to 26 day and from 26 to 14 days due to the NSRTN.</p

The cost at each of the 19 hubs before and after the initiation of the National sample referral transport network (NSRTN).

<p>The cost at each of the 19 hubs before and after the initiation of the National sample referral transport network (NSRTN).</p

The cost in 2010 before the network was started compared to when additional costs for start up of the transport network were added.

<p>The cost in 2010 before the network was started compared to when additional costs for start up of the transport network were added.</p